Efficient Delivery of Therapeutic siRNA with Nanoparticles Induces Apoptosis in Prostate Cancer Cells

Figure 1

Characterization of the PEG-LP/siRNA NPs. (a) Schematic diagram of the prepared NPs structure. (b) Mean particle size of the prepared NPs measured by DLS. (c) Gel retardation assay of siRNA complexed with nanoparticles at different N/P ratios. (d) Transmission electron microscopic image of prepared NPs.

(a)

(b)

(c)

(d)